Skip to main content

Merck Licenses Ingenuity Pathways Analysis Software

NEW YORK, Dec. 6 (GenomeWeb News) - Merck has taken a multi-year license to Ingenuity's Pathways Analysis software for use by its scientists worldwide, the companies said today.


Under the multi-year license, Merck plans to use the application, which contains information about biological networks and pathways curated from the scientific literature, together with its own tools for molecular profiling.


Merck will also integrate Ingenuity Pathways Analysis with its own bioinformatics systems.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.